You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 3,725,548


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,725,548
Title: SUBSTITUTED INDENYL ACETIC ACIDS IN THE TREATMENT OF PAIN, FEVER OR INFLAMMATION
Abstract:New substituted indenyl acetic acids and nontoxic pharmaceutically acceptable amides, esters and salts derived therefrom. The substituted indenyl acetic acids disclosed herein have anti-inflammatory, anti-pyretic and analgesic activity. Also included herein are methods of preparing said indenyl acetic acid compounds, pharmaceutical compositions having said indenyl acetic acid compounds as an active ingredient and methods of treating inflammation by administering these particular compositions to patients.
Inventor(s): Shen; Tsung-Ying (Westfield, NJ), Greenwald; Richard B. (Framingham, MA), Jones; Howard (Holmdel, NJ), Linn; Bruce O. (Somerville, NJ), Witzell; Bruce E. (Westfield, NJ)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:05/187,197
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;
Patent landscape, scope, and claims:

United States Patent 3,725,548: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 3,725,548, though not specifically detailed in the provided sources, can be analyzed using general principles and tools available for patent analysis. Here, we will delve into the steps and considerations for understanding the scope, claims, and broader patent landscape of any U.S. patent, using this patent as a case study.

Understanding the Patent Document

To analyze a patent, the first step is to obtain the patent document itself. This can be done through the U.S. Patent and Trademark Office (USPTO) database or other patent search tools like the Patent Public Search tool or the Patent and Trademark Resource Centers (PTRCs)[4].

Patent Claims

Claim Structure

Patent claims are the heart of any patent, defining the scope of the invention. Claims are typically categorized into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Claim Analysis

For U.S. Patent 3,725,548, you would need to identify and analyze each claim to understand the specific aspects of the invention that are protected. This involves examining the language and scope of each claim, including any limitations or dependencies.

Patent Scope

Determining Patent Scope

The scope of a patent is determined by its claims, but it is also influenced by the description and drawings provided in the patent specification. The Patent Claims Research Dataset by the USPTO can provide insights into claim-level statistics and document-level statistics, which can help in understanding the scope of patents in general[3].

Interpretation of Claims

Claims are interpreted in light of the specification and drawings. This means that the language used in the claims must be understood in the context of the entire patent document. Any ambiguities or unclear terms are resolved by referring to the description and drawings.

Prior Art and Patentability

Conducting a Prior Art Search

To understand the patent landscape, it is crucial to conduct a prior art search. This involves searching existing patents, published patent applications, and other relevant documents to identify any prior inventions that may affect the patentability of the claims in U.S. Patent 3,725,548. Tools like the Patent Public Search, Global Dossier, and Common Citation Document (CCD) can be used for this purpose[4].

Patentability Analysis

The patentability of the claims in U.S. Patent 3,725,548 would be evaluated based on the prior art search. This involves assessing whether the claims are novel, non-obvious, and meet the other statutory requirements for patentability.

Obviousness-Type Double Patenting (ODP)

Understanding ODP

Obviousness-type double patenting (ODP) is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention that is obvious over a first patent. This is relevant when dealing with continuation-in-part patents or patents that have received Patent Term Adjustments (PTA)[1].

Application to U.S. Patent 3,725,548

If U.S. Patent 3,725,548 is part of a patent family with other related patents, an ODP analysis might be necessary to ensure that the claims do not overlap in a way that would render them unpatentable.

Patent Term and Adjustments

Patent Term

The patent term for U.S. patents is generally 20 years from the filing date of the earliest non-provisional application. However, Patent Term Adjustments (PTA) can extend this term if there are delays during the prosecution process[1].

Impact on U.S. Patent 3,725,548

If U.S. Patent 3,725,548 received a PTA, it would be important to understand how this affects its expiration date and any potential ODP issues.

Litigation and Enforcement

Patent Litigation

In the event of a dispute, understanding the scope and claims of U.S. Patent 3,725,548 is crucial for litigation. This involves analyzing the patent in the context of the alleged infringement and any prior art that may be raised as a defense.

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could potentially simplify and reduce the costs associated with patent litigation for smaller entities[5].

Global Patent Landscape

International Patent Family

Using tools like the Global Dossier, you can identify related applications filed at participating IP Offices. This helps in understanding the global patent family and any international implications for U.S. Patent 3,725,548[4].

Harmonization Efforts

The Common Citation Document (CCD) application consolidates prior art cited by multiple offices, facilitating a more integrated global patent system. This can be useful in assessing the global patent landscape for U.S. Patent 3,725,548[4].

Key Takeaways

  • Patent Claims: The claims define the scope of the invention and must be carefully analyzed.
  • Prior Art Search: Conducting a thorough prior art search is essential for understanding patentability.
  • ODP Analysis: Ensure that the patent does not fall under obviousness-type double patenting.
  • Patent Term Adjustments: Understand how PTA affects the patent term and any potential ODP issues.
  • Global Landscape: Use tools like Global Dossier and CCD to understand the international patent family and global implications.

FAQs

Q: How do I find the full text of U.S. Patent 3,725,548?

A: You can find the full text of U.S. Patent 3,725,548 through the USPTO's Patent Public Search tool or by visiting a Patent and Trademark Resource Center (PTRC)[4].

Q: What is the significance of prior art in patent analysis?

A: Prior art is crucial for determining the novelty and non-obviousness of the invention, which are key requirements for patentability.

Q: How does Obviousness-Type Double Patenting (ODP) affect patents?

A: ODP prevents an inventor from securing a second, later-expiring patent for an invention that is obvious over a first patent, ensuring that the patent term is not extended unfairly[1].

Q: What is the role of Patent Term Adjustments (PTA) in patent law?

A: PTA extends the patent term if there are delays during the prosecution process, but it does not extend the term past the date of a terminal disclaimer[1].

Q: How can I determine the global patent family for U.S. Patent 3,725,548?

A: Use the Global Dossier service to identify related applications filed at participating IP Offices and understand the global patent family[4].

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1].
  2. U.S. Patent and Trademark Office (USPTO) - USA.gov[2].
  3. Patent Claims Research Dataset - USPTO[3].
  4. Search for patents - USPTO[4].
  5. U.S. Patent Small Claims Court - Administrative Conference of the United States (ACUS)[5].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 3,725,548

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 3,725,548

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 193345 ⤷  Subscribe
Austria 312585 ⤷  Subscribe
Austria 313263 ⤷  Subscribe
Austria 315826 ⤷  Subscribe
Austria 321291 ⤷  Subscribe
Austria 326647 ⤷  Subscribe
Austria 327182 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.